Overview

Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

Status:
Not yet recruiting

Trial end date:
2023-11-30

Target enrollment:

Participant gender:

Summary

This study aims to evaluate the possible antifibrotic effect of zinc sulphate in chronic HCV patient receiving direct acting anti-viral therapy

Phase:

Phase 3

Details

Lead Sponsor:

Tanta University